SuspensionSuspension
Schedule H (Prescription Required)Anthelmintics & Anti-ParasiticCode: 2435

Mebendazole Oral Suspension 100mg per ml

Generic Formulation:Mebendazole Oral Suspension 100mg per ml
Pack Size:30ml

MRP Under Process

Official PMBI MRP is being updated for catalog code 2435.

Locate Jan Aushadhi Kendra
Clinical InformationReport Error

Clinical Overview

Mebendazole is a synthetic broad-spectrum benzimidazole anthelmintic. It binds specifically to parasitic beta-tubulin, selectively inhibiting microtubule formation in intestinal cells of helminths, leading to irreversible disruption of glucose uptake and death of the parasite. Minimal systemic absorption (<10%) ensures high concentrations within the gut lumen. Indicated for ascariasis (roundworm), trichuriasis (whipworm), enterobiasis (pinworm), and hookworm infections.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 2435.Report inaccuracy

Usage Guidelines

Shake suspension well before measuring dose. Can be given with or without food. Fasting or laxative use is not required before treatment.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Transient abdominal cramps, mild diarrhea, flatulence. Rare/Severe: Angioedema, Stevens-Johnson syndrome, hepatitis, and neutropenia (associated with prolonged high doses).

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Contraindicated in pregnancy. Not recommended in children under 2 years of age due to seizure reports. Avoid concurrent use with metronidazole due to increased risk of Stevens-Johnson syndrome / toxic epidermal necrolysis.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.